We also found that a SUMO-modified site in BORF2 (K741) plays an important role in the formation of bodies with endogenous APOBEC3B, both when expressed on its own and in the context of EBV infection. The gene discussed is APOBEC3B; the disease is Epstein-Barr virus infection.